EMERGENT BIOSOLUTIONS INC. COMMON STOCK

Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis

28 Mar 2024 07:15:03 By Nasdaq GlobeNewswire

Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility

25 Mar 2024 07:05:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results

06 Mar 2024 15:31:01 By Nasdaq GlobeNewswire

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

29 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

21 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

06 Feb 2024 08:45:22 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

05 Feb 2024 08:47:20 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

02 Feb 2024 08:47:25 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

01 Feb 2024 08:45:21 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

31 Jan 2024 08:45:41 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

30 Jan 2024 11:27:22 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

29 Jan 2024 08:53:19 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

19 Jan 2024 08:46:42 By NetDania Notify

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

11 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

09 Jan 2024 06:30:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

28 Nov 2023 05:59:00 By Nasdaq GlobeNewswire

Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing

24 Nov 2023 06:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

13 Nov 2023 09:10:33 By NetDania Notify

NetDania - New 12 months Low: EMERGENT BIOSOLUTIONS INC. COMMON STOCK

10 Nov 2023 09:16:40 By NetDania Notify

Emergent BioSolutions Reports Third Quarter 2023 Financial Results

08 Nov 2023 16:38:16 By Nasdaq GlobeNewswire